Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hales

Showing results (191-200 of 201) with videos related to

Pageof 21
Sort By:
Brain : a Journal of Neurology|December 17, 2021
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairmentAllan I Levey, Deqiang Qiu, Liping Zhao, et al.
Nature Neuroscience|January 10, 2018
TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTDChing-Chieh Chou, Yi Zhang, Mfon E Umoh, et al.
Neuron|February 1, 2024
APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer's disease pathologyAugustine Chemparathy, Yann Le Guen, Sunny Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 2013
U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's diseaseBing Bai, Chadwick M Hales, Ping-Chung Chen, et al.
Neuron|May 7, 2020
Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36Zachary T McEachin, Tania F Gendron, Nisha Raj, et al.
Molecular Neurodegeneration|March 13, 2025
Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disordersUdit Sheth, Linn Öijerstedt, Michael G Heckman, et al.
Science Translational Medicine|June 26, 2024
Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiencyJohn V Pluvinage, Thomas Ngo, Camille Fouassier, et al.
Journal of Neurology|April 30, 2026
Factors influencing accelerated progression in behavioral variant frontotemporal dementiaMolly Split, Zachary J Kunicki, Daliah Ross, et al.
Nature Aging|May 16, 2025
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degenerationRowan Saloner, Adam M Staffaroni, Eric B Dammer, et al.
Nature Aging|July 7, 2025
Author Correction: Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degenerationRowan Saloner, Adam M Staffaroni, Eric B Dammer, et al.
Pageof 21

Showing results (191-200 of 201) with videos related to

Sort By:
Pageof 21
Brain : a Journal of Neurology|December 17, 2021
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairmentAllan I Levey, Deqiang Qiu, Liping Zhao, et al.
Nature Neuroscience|January 10, 2018
TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTDChing-Chieh Chou, Yi Zhang, Mfon E Umoh, et al.
Neuron|February 1, 2024
APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer's disease pathologyAugustine Chemparathy, Yann Le Guen, Sunny Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 2013
U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's diseaseBing Bai, Chadwick M Hales, Ping-Chung Chen, et al.
Neuron|May 7, 2020
Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36Zachary T McEachin, Tania F Gendron, Nisha Raj, et al.
Molecular Neurodegeneration|March 13, 2025
Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disordersUdit Sheth, Linn Öijerstedt, Michael G Heckman, et al.
Science Translational Medicine|June 26, 2024
Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiencyJohn V Pluvinage, Thomas Ngo, Camille Fouassier, et al.
Journal of Neurology|April 30, 2026
Factors influencing accelerated progression in behavioral variant frontotemporal dementiaMolly Split, Zachary J Kunicki, Daliah Ross, et al.
Nature Aging|May 16, 2025
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degenerationRowan Saloner, Adam M Staffaroni, Eric B Dammer, et al.
Nature Aging|July 7, 2025
Author Correction: Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degenerationRowan Saloner, Adam M Staffaroni, Eric B Dammer, et al.
Pageof 21